It is interesting that in the COMFORT-I trial they reported that using the same criteria for transfusion independence (IWG-MRT) that YM reports with, that 46.9% of their patients on the placebo arm become transfusion independent. Based on this, until I see YM reporting their rate next to placebo or therapeutic alternatives, I gonna remain a little skeptical of their claims.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.